Wong Lab Publications
Learn more about research being performed in the Wong Lab by reading our latest publications.
Recent Publications
Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors
Cancer research communications. 2025 Nov 26;
TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy
Cancer research. 2025 Oct 15; 85:3966-3982
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945
NPJ precision oncology. 2025 Aug 20; 9:294
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
Prostate cancer & prostatic diseases. 2025 Jun ; 28:363-369
Surgical Resection of Murine PDAC Alters Hepatic Metastases and Immune Microenvironment
Pancreas. 2025 May 23;
In Vivo Efficacy of a Macrocyclic Peptoid-Peptide Hybrid That Selectively Modulates the Beta-Catenin/TCF Interaction to Inhibit Prostate Cancer
Prostate. 2025 May ; 85:646-658
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C
Cancer discovery. 2025 Mar 03; 15:578-594
Characterization of tumour heterogeneity through segmentation-free representation learning on multiplexed imaging data
Nature biomedical engineering. 2025 Mar ; 9:405-419